Biopharmaceuticals
Generics
Oncology
Product Launch
News Release - August 5, 2015
Hetero Announces the Launch of Biosimilar Rituximab (MABALL(TM)) in India
Source: Hetero Group
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.